Venus Remedies has been granted patent by European Patent Office (EPO) for its research drug “ACHNIL” a once a day painkiller injection. This patent grant will be in force till 2025 in the member countries of EPO which will further reinforce the market position of the company in the major economies such as Germany, UK, France, Spain, Sweden, Italy and Switzerland.
Earlier the same formulation was granted by the Indian patent Office. This is the second European patent success for the company after Sulbactomax. This novel formulation based on NDDS (Novel Drug Delivery System) technology is going to fillip the gap of long standing demand for better pain management therapy.
ACHNIL starts its action instantly by giving immediate relief from acute pain and is effective for the next 24 hours as against the conventional daily dose of three injections of diclofenac given every 8 hours.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1657.45 |
| Dr. Reddys Lab | 1212.50 |
| Cipla | 1228.00 |
| Zydus Lifesciences | 927.55 |
| Lupin | 2307.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: